Neelam is MedCity’s interim CEO, responsible for leading the team and operations, driving the strategy and relationships with key stakeholders and funders. She is also the lead for clinical trials, supporting companies seeking clinical and research expertise and collaborations. Neelam has extensive experience in Pharma, R&D, NIHR service improvement & strategy. Neelam has been a pivotal member of the MedCity team since 2014, as COO and also as their lead for supporting industries looking for clinical trial and evidence generation support. Neelam has a breadth of experience across the sector, having held leadership positions in the pharmaceutical industry, the National Institute of Health Research and supporting health charities and the NHS. Neelam was a speaker at the AI for Longevity Summit 2019.